Crystallographic Approach to Identification of Cyclin-dependent Kinase 4 (CDK4)-specific Inhibitors by Using CDK4 Mimic CDK2 Protein
Open Access
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (29), 27548-27554
- https://doi.org/10.1074/jbc.m102060200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current statusExpert Opinion on Investigational Drugs, 2000
- Cancer Cell CyclesScience, 1996
- Differences in Substrate Specificity between Cdk2-Cyclin A and Cdk2-Cyclin E in VitroBiochemical and Biophysical Research Communications, 1995
- Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitionsFEBS Letters, 1994
- Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275Biochemical and Biophysical Research Communications, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Purification and Crystallization of Human Cyclin-dependent Kinase 2Journal of Molecular Biology, 1993
- Free R value: a novel statistical quantity for assessing the accuracy of crystal structuresNature, 1992
- Slow-cooling protocols for crystallographic refinement by simulated annealingActa Crystallographica Section A Foundations of Crystallography, 1990
- In vitro phosphorylation of the tumor suppressor gene RB protein by mitosis-specific histone H1 kinaseBiochemical and Biophysical Research Communications, 1989